Patuletin

Patuletin is a naturally occurring flavonol aglycone found in plants such as Artemisia and Calendula species, structurally characterized by a 6-hydroxyquercetin backbone. It exerts its primary biological effects through inhibition of lipoxygenase enzymes, free radical scavenging via its catechol B-ring, and modulation of cell-cycle arrest pathways in cancer cell lines.

Origin & History

Patuletin is an O-methylated flavonol (6-methoxyquercetin) found naturally in the flowers of Tagetes patula (French marigold) and various species including Eriocaulon, Ipomopsis aggregata, Echinacea angustifolia, and Kalanchoe brasiliensis. It occurs as a plant pigment in flowers and aerial parts, though specific extraction methods are not detailed in available research.

Historical & Cultural Context

No historical or traditional medicinal uses for patuletin are documented in the available research sources. Its identification and study appear to be relatively recent, focused on its role as a plant pigment and potential bioactive compound.

Health Benefits

• Anti-proliferative effects against cancer cells (preliminary in vitro evidence only)
• Antioxidant activity (mechanism identified but no clinical studies)
• Analgesic (pain-relieving) properties (mechanism proposed but no human trials)
• Lipoxygenase inhibition (biochemical activity identified in preclinical research)
• Limited evidence base - no human clinical trials have been conducted

How It Works

Patuletin inhibits 5-lipoxygenase (5-LOX) and 12-lipoxygenase (12-LOX), enzymes responsible for converting arachidonic acid into pro-inflammatory leukotrienes, thereby reducing inflammatory signaling at the biochemical level. Its 3,4-dihydroxy catechol group on the B-ring donates hydrogen atoms to neutralize reactive oxygen species, including superoxide and hydroxyl radicals, contributing to its antioxidant potency exceeding that of quercetin in some assays. In cancer cell models, patuletin has been shown to induce G2/M cell-cycle arrest and upregulate caspase-3-dependent apoptotic pathways, likely through modulation of cyclin B1 and CDK1 expression.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses on patuletin have been conducted to date. Current evidence is limited to preclinical in vitro studies showing anti-proliferative activity against cancer cells, with potential involvement of MAPK/ERK, NF-κB, and PI3K/Akt/mTOR pathways.

Clinical Summary

All available evidence for patuletin's biological activity derives from in vitro cell culture studies and limited ex vivo biochemical assays; no human clinical trials or randomized controlled studies have been conducted specifically on patuletin as an isolated compound. In vitro studies have demonstrated anti-proliferative activity against HeLa cervical carcinoma cells and MCF-7 breast cancer cells at concentrations typically ranging from 10–100 µM, though these concentrations are not confirmed achievable in human plasma through dietary or supplemental intake. Lipoxygenase inhibition has been quantified in cell-free enzymatic assays with IC50 values in the low micromolar range, offering mechanistic plausibility for analgesic and anti-inflammatory effects but no clinical confirmation. Overall, the evidence base is preliminary and insufficient to support any therapeutic claims for human use.

Nutritional Profile

Patuletin (3,3',4',5,7-pentahydroxy-6-methoxyflavone) is a flavonoid compound, not a macronutrient source — it contributes no meaningful calories, protein, fat, or fiber when encountered in trace dietary amounts. It is a 6-methoxylated derivative of quercetin, found at low concentrations (typically <0.1% dry weight) in plants such as Artemisia species, marigold (Calendula officinalis), and certain Asteraceae family members. As a bioactive polyphenol, its biological relevance is purely pharmacological rather than nutritional. Bioavailability data is sparse, but like quercetin analogues, intestinal absorption is expected to be limited (estimated <5% without modification), with methylation at the 6-position potentially influencing metabolic stability versus quercetin. It undergoes phase II conjugation (glucuronidation, sulfation) in the gut wall and liver. No established dietary reference intake exists.

Preparation & Dosage

No clinically studied dosage ranges have been established for patuletin in any form (extract, powder, or standardized preparations). Human dosing guidelines are not available due to lack of clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin pairs most logically with patuletin given their near-identical flavonoid backbone, with quercetin's more established lipoxygenase and COX-inhibition data complementing patuletin's anti-proliferative signaling through additive NF-κB pathway modulation. Piperine (from black pepper, ~5–20 mg range) may enhance patuletin's bioavailability by inhibiting CYP3A4 and P-glycoprotein efflux, a mechanism well-documented with structurally similar flavonoids. Luteolin shares overlapping anti-inflammatory targets (5-LOX, COX-2 suppression) and may act additively with patuletin's lipoxygenase inhibition, while vitamin C (ascorbic acid, 500 mg range) can regenerate the oxidized radical form of patuletin back to its active antioxidant state, extending its reactive oxygen species-scavenging duration.

Safety & Interactions

No human safety studies, toxicology trials, or established tolerable upper intake levels exist specifically for isolated patuletin supplementation, making definitive safety conclusions impossible at this time. Because patuletin inhibits lipoxygenase enzymes, theoretical interactions with NSAIDs and other anti-inflammatory drugs are plausible, as combined use could exaggerate effects on arachidonic acid metabolism. Patuletin's structural similarity to quercetin raises the possibility of interactions with cytochrome P450 enzymes, particularly CYP3A4 and CYP2C9, which could theoretically alter metabolism of warfarin, statins, or immunosuppressants, though this has not been studied directly. Pregnant or breastfeeding individuals should avoid isolated patuletin supplements due to a complete absence of safety data in these populations.